“Neuregulin-4 (Nrg-4) As a Metabolic Regulator: A Comprehensive Review of Its Association With Dyslipidemia and Liver Function Abnormalities in Newly Diagnosed Type 2 Diabetes Mellitus”. Vascular and Endovascular Review, vol. 8, no. 19s, Dec. 2025, pp. 177-81, https://doi.org/10.64149/J.Ver.8.19s.177-181.